North America non-invasive aesthetic treatment Market Size, Growth, Trends | Report 2022-2030
The North America non-invasive aesthetic treatment market was surpassed at USD 19.42 billion in 2021 and is expected to hit around USD 47.86 billion by 2030, growing at a CAGR of 10.54% from 2022 to 2030
Report Highlights
Non-invasive aesthetic treatments are procedures that do not require surgical intervention, have minimal downtime, lower risks of complications, and lower cost of treatment. The market growth is attributed to the rising demand for fillers and injectable including Botox as a result of the increasing target population across the globe. The demand for anti-aging aesthetic solutions that are non-invasive has escalated due to the increasing geriatric population pool.
According to the American Society of Plastic Surgeons (ASPS), high growth was observed in facial rejuvenation procedures, and the number of botulinum toxin type A procedures was the highest, accounting for over 7.7 million injections (Botox, Dysport, Xeomin) in 2019. It was also noted that in 2019, around 4,73,354 botulinum toxin filler procedures were performed on men in the U.S. This indicates that demand for the procedure is rapidly increasing among men.
The U.S is among the top countries to carry out non-invasive aesthetic treatments globally as the acceptance towards advanced procedures is higher in the country. Moreover rising disposable income, superior medical infrastructure, the prevalence of skin conditions, and a large pool of aesthetic professionals are expected to boost the market growth.
In the light of COVID-19, the global non-invasive aesthetic treatment market was hampered as the footfall of patient appointments for aesthetic treatments was temporarily suspended. The American Society of Plastic Surgeons stated that the pandemic reduced the overall uptake of aesthetic treatments; however, it will be the reason for an upsurge in demand for cosmetic procedures in the coming years, which is expected to rise even higher than previous numbers.
Scope of The Report
| Report Coverage | Details |
| Market Size in 2021 | USD 19.42 billion |
| Revenue Forecast by 2030 | USD 47.86 billion |
| Growth rate from 2022 to 2030 | CAGR of 10.54% |
| Base Year | 2021 |
| Forecast Period | 2022 to 2030 |
| Segmentation | Procedure, end-use, region |
| Companies Covered | Toronto Cosmetic Clinic (TCC); The Cosmetic Clinic; Skinovative of Gilbert-Medical Spa; Shea Aesthetic Clinic; Chapter Aesthetic Studio; AnewSkin Medspa; The Ottawa Skin Clinic; Manhattan Aesthetics; Toronto Medical Aesthetics; Dr. Cory Torgerson; Canada MedLaser, Inc.; SkinRhümMD; Skin Vitality Medical Clinic; and True MediSpa; Dermapure |
Procedure Insights
In 2021, the injectable segment dominated the market for non-invasive aesthetic treatment in North America and held the largest revenue share of 54.46% in 2021. The segment is expected to show the highest CAGR over the forecast period. This is mainly because there is a wide application of injectable in aesthetic treatment. Also, dermal injections are effective, show the immediate result, have high patient satisfaction and low recovery period attributing to the high segment growth. Besides, as per the American Society of Dermatology Surgery, the injectable is the most performed procedure in the U.S. It also revealed that filler treatments witnessed an increase of 78% over the course of 8 years in the U.S.
The skin rejuvenation segment held a revenue share of 30.7% in 2021 owing to the advancement in procedures like photo rejuvenation, deep chemical peel, and laser resurfacing. The chemical peels of skin rejuvenation segment, held the highest market share in 2021, as it helps treat skin damage, acne scars, discoloration, hyperpigmentation, and wrinkles. However, the others segment which includes hair removal, non-surgical fat reduction, sclerotherapy, cellulite treatment is expected to show significant growth over the forecast period.
End-use Insights
The MedSpa segment dominated the market for non-invasive aesthetic treatment in North America and held the highest revenue share of 34.38% in 2021. A Medspa is a facility where cosmetic services are provided under the supervision of a licensed physician. They are also known as cosmetic clinics or esthetic centers. Med spas are generally a combination of aesthetic medical centers and day spas that offer corrective medical skincare treatments and products. These facilities follow all the regulatory policies and standards set by the government.
Medspas are increasingly adopting novel treatment systems to cater to a wider esthetic need of patients. The employees in Medspa need to have a license in esthetics as well as a medical education. In 2017, the American Med Spa Association (AmSpa) reported that more than 4,200 Medspas are operating in the U.S. and this number has increased by 50% since 2016. Factors such as membership subscriptions, service marketing, adoption of novel laser technologies, and cost-effective treatments are expected to significantly boost the med spa segment.
Regional Insights
The U.S dominated the market for non-invasive aesthetic treatment in North America and accounted for the largest revenue share of 85.03% in 2021. The segment is expected to showcase a significant CAGR over the forecast period. This is attributed to the strong medical infrastructure, well-established reimbursement policies, the existence of key market players, and the high adoption of novel aesthetic procedures. Moreover, attributes like high acceptance and openness towards aesthetic treatments, and soaring appearance-conscious customer pool is likely to propel market growth.
Canada is also witnessing growth in the non-invasive aesthetic treatment especially for the injectable segment largely due to the fact that nearly one in every five women in Canada is dissatisfied with her appearance. High healthcare expenditure and the presence of advanced healthcare facilities are some of the key factors fueling the growth of the market for non-invasive aesthetic treatment in Canada.
Key Players
Market Segmentation
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on North America Non-invasive Aesthetic Treatment Market
5.1. COVID-19 Landscape: North America Non-invasive Aesthetic Treatment Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global North America Non-invasive Aesthetic Treatment Market, By Procedure
8.1. North America Non-invasive Aesthetic Treatment Market, by Procedure, 2022-2030
8.1.1. Injectables
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Skin Rejuvenation
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Others
8.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global North America Non-invasive Aesthetic Treatment Market, By End-use
9.1. North America Non-invasive Aesthetic Treatment Market, by End-use, 2022-2030
9.1.1. Hospital/Surgery Center
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Medspa
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Traditional Spa
9.1.3.1. Market Revenue and Forecast (2017-2030)
9.1.4. HCP owned clinic
9.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global North America Non-invasive Aesthetic Treatment Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, by Procedure (2017-2030)
10.1.2. Market Revenue and Forecast, by End-use (2017-2030)
10.1.3. U.S.
10.1.3.1. Market Revenue and Forecast, by Procedure (2017-2030)
10.1.3.2. Market Revenue and Forecast, by End-use (2017-2030)
10.1.4. Rest of North America
10.1.4.1. Market Revenue and Forecast, by Procedure (2017-2030)
10.1.4.2. Market Revenue and Forecast, by End-use (2017-2030)
Chapter 11. Company Profiles
11.1. Toronto Cosmetic Clinic (TCC)
11.1.1. Company Overview
11.1.2. Procedure Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. The Cosmetic Clinic
11.2.1. Company Overview
11.2.2. Procedure Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Skinovative of Gilbert-Medical Spa
11.3.1. Company Overview
11.3.2. Procedure Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Shea Aesthetic Clinic
11.4.1. Company Overview
11.4.2. Procedure Offerings
11.4.3. Financial Performance
11.4.4. LTE Scientific
11.5. Chapter Aesthetic Studio
11.5.1. Company Overview
11.5.2. Procedure Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. AnewSkin Medspa
11.6.1. Company Overview
11.6.2. Procedure Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. The Ottawa Skin Clinic
11.7.1. Company Overview
11.7.2. Procedure Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Manhattan Aesthetics
11.8.1. Company Overview
11.8.2. Procedure Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Toronto Medical Aesthetics
11.9.1. Company Overview
11.9.2. Procedure Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Dr. Cory Torgerson
11.10.1. Company Overview
11.10.2. Procedure Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers